| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |